Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Oncotelic Therapeutcs Inc (OP:OTLC)

0.0364 UNCHANGED
Streaming Delayed Price Updated: 3:44 PM EDT, Apr 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Oncotelic Therapeutcs Inc

< Previous 1 2 3 4 Next >
AINewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured In Editorial On AI-Driven Transformation of Pharmaceutical Manufacturing
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages
Via Investor Brand Network
Topics Artificial Intelligence
AINewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in AINewsWire Editorial on AI-Driven Pharma Compliance
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
News headline image
AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages
From AINewsWire
Via GlobeNewswire
From Big Data to Better Drugs: How AI-Driven Platforms Are Changing Cancer Research
Via Investor Brand Network
AI-Driven Compliance Gamechanger in Pharma Manufacturing and Regulatory Standards
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
AI-Driven Compliance Gamechanger in Pharma Manufacturing and Regulatory Standards
From AINewsWire
Via GlobeNewswire
TechMediaBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Enters Robotics And AI Biopharma Partnership With Oncotelic Therapeutics (OTCQB: OTLC)
Via Investor Brand Network
Topics Artificial Intelligence
BioMedNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Partners with TechForce Robotics to Advance AI-Enabled GMP Automation Platform
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
News headline image
Oncotelic Therapeutics Announces Strategic Partnership with TechForce Robotics to Commercialize PDAOAI-Enhanced GMP Robotics Platform
From Oncotelic Therapeutics, Inc.
Via GlobeNewswire
BioMedNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) To Present Deciparticle Platform And Pipeline At BIO-Europe Spring 2026
Via Investor Brand Network
Topics Artificial Intelligence Regulatory Compliance
BioMedNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Subsidiary Sapu Nano To Present Everolimus Toxicology Data At SOT 2026
Via Investor Brand Network
Topics Artificial Intelligence Regulatory Compliance
News headline image
Growth Stocks: NGTF, AMLM, CSDX, OTLC, ECGI Across Robotics, Precious Metals, MedTech and Blockchain
Via AB Newswire
Topics Economy Intellectual Property
BioMedNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured In NetworkNewsAudio On Biotech M&A Trends
Via Investor Brand Network
Topics Intellectual Property
News headline image
NetworkNews Audio Announces Audio Press Release (APR) Discussing Growing Investor Attention on Companies Holding Clinical-Stage Portfolios
From NetworkNewsWire
Via GlobeNewswire
BioMedNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on CNS and Oncology Momentum
Via Investor Brand Network
Topics Intellectual Property
News headline image
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Announces Expanded IP Coverage, Strengthening Position in Biotech Evolution
From Oncotelic Therapeutics, Inc.
Via GlobeNewswire
Drug-Delivery Breakthroughs, Cross-Indication Research Accelerate New Momentum in CNS and Oncology Development
Via Investor Brand Network
Topics Intellectual Property
News headline image
Drug-Delivery Breakthroughs, Cross-Indication Research Accelerate New Momentum in CNS and Oncology Development
From BioMedWire
Via GlobeNewswire
BioMedNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Late-Stage Biotech M&A Trends
Via Investor Brand Network
Topics Intellectual Property
News headline image
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Key IP Portfolio Advancements Align with Biotech Asset Trend
From Oncotelic Therapeutics, Inc.
Via GlobeNewswire
Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A
Via Investor Brand Network
Topics Intellectual Property
BioMedNewsBreaks — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Expands Global Intellectual Property Portfolio Supporting OT-101 Across Neurology and CNS Delivery
Via Investor Brand Network
Topics Intellectual Property
News headline image
Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A
From BioMedWire
Via GlobeNewswire
News headline image
Oncotelic Therapeutics, Inc. and Sapu Bioscience Expand International IP Coverage for OT-101, Strengthening CNS and Neurology Commercialization Pathway
From Oncotelic Therapeutics, Inc.
Via GlobeNewswire
News headline image
Oncotelic Therapeutics, Inc. Showcases Multi-Year Execution and Validation, Enters 2026 with Late-Stage Momentum Across Diversified Pipeline
From Oncotelic Therapeutics, Inc.
Via GlobeNewswire
BioMedNewsBreaks — Oncotelic Therapeutics Inc.’s (OTLC) Deciparticle(TM) Platform Expands Possibilities in Immunology and Oncology
Via Investor Brand Network
Topics Intellectual Property
InvestorNewsBreaks – Oncotelic Therapeutics Inc. (OTLC) Advances Nanoparticle Drug Delivery, Prepares First-in-Human Study of IV Everolimus
Via Investor Brand Network
Topics Intellectual Property
Oncotelic Therapeutics Inc. (OTLC) Unveils Breakthrough Nanomedicine Platform, Expands Everolimus (Afinitor(R)) Pipeline
Via Investor Brand Network
BioMedNewsBreaks — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Opens Research Access to PDAOAI Evidence Interrogation Platform
Via Investor Brand Network
Topics Artificial Intelligence Regulatory Compliance
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.